Sumorek-Wiadro, J.; Zając, A.; Skalicka-Woźniak, K.; Rzeski, W.; Jakubowicz-Gil, J.
Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro. Int. J. Mol. Sci. 2024, 25, 759.
https://doi.org/10.3390/ijms25020759
AMA Style
Sumorek-Wiadro J, Zając A, Skalicka-Woźniak K, Rzeski W, Jakubowicz-Gil J.
Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro. International Journal of Molecular Sciences. 2024; 25(2):759.
https://doi.org/10.3390/ijms25020759
Chicago/Turabian Style
Sumorek-Wiadro, Joanna, Adrian Zając, Krystyna Skalicka-Woźniak, Wojciech Rzeski, and Joanna Jakubowicz-Gil.
2024. "Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro" International Journal of Molecular Sciences 25, no. 2: 759.
https://doi.org/10.3390/ijms25020759
APA Style
Sumorek-Wiadro, J., Zając, A., Skalicka-Woźniak, K., Rzeski, W., & Jakubowicz-Gil, J.
(2024). Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro. International Journal of Molecular Sciences, 25(2), 759.
https://doi.org/10.3390/ijms25020759